Report on Johnson and Johnson

project report on johnson & johnson's ltd. - November 14th, 2009

________________________________________

HISTORY OF THE COMPANY:

One of America's most admired companies, Johnson & Johnson (J & J) is one of the largest healthcare firms in the world and one of the most diversified. Its operations are organized into three business segments: pharmaceutical, which generates 39 percent of revenues and 61 percent of operating income; professional, which accounts for 36 percent of revenues and 27 percent of operating income; and consumer, which contributes 25 percent of revenues and 12 percent of operating income. J & J's pharmaceutical products--which are sold under such brands as Janssen Pharmaceutica, Ortho-McNeil Pharmaceutical, and Centocor--include drugs for family planning, mental illness, gastroenterology, oncology, pain management, and other areas. The professional segment includes surgical and patient care equipment and devices, diagnostic products, joint replacements, and disposable contact lenses. The company's well-known line of consumer products includes the Johnson's baby care line, the Neutrogena skin and hair care line, Tylenol and Motrin pain relievers, o.b. and Stayfree feminine hygiene products, the Reach oral care line, Band-Aid brand adhesive bandages, Imodium A-D diarrhea treatment, Mylanta gastrointestinal products, and Pepcid AC acid controller. J & J generates about half of its revenues outside the United States, through its network of 190 operating companies in 51 countries and its marketing organization that sells in more than 175 countries.

Johnson & Johnson was founded more than 120 years ago on a revolutionary idea: Doctors and nurses should use sterile sutures, dressings and bandages to treat peoples' wounds. Since then, the company brought the world new ideas and products that have transformed human health and well-being. Every invention, every product, every breakthrough has been powered by generations of employees who are inspired to make a difference.

Explore the rich history as well as the recent advances from the company:

Since the founding in 1886, the company has grown to meet the health care needs of people worldwide. Through mergers, acquisitions and the formation of new companies, they have become the world's largest and most broadly based health care company. Here are some highlights of the historical growth.

1886 - 1926: Johnson & Johnson Founded With Surgical and Wound Care Products

In 1886, the founders - Robert Wood Johnson, James Wood Johnson and Edward Mead Johnson - started a small medical products company in New Brunswick, New Jersey. They made the first-ever commercial sterile surgical dressings, which helped save the lives of patients.

* They introduced dental floss, the first First Aid kits, sanitary napkins for women, sterile sutures, JOHNSON'S® Baby Powder, and BAND-AID® Brand Adhesive Bandages.

* The international expansion began with Canada in 1919 and England in 1924.

* Their disaster relief program began in 1906 when, within hours of the San Francisco earthquake and fire, they sent trainloads of their products to the city to help survivors.

1926 - 1946: Growth of Product Lines and Expansion Overseas Help Johnson & Johnson Go Public

In 1943 the chairman Robert Wood Johnson wrote Our Credo, outlining the responsibilities to doctors, nurses, patients, consumers, employees, and the community. During this period they also continued their overseas growth and began to broaden the efforts in pharmaceuticals and medical products.

They expanded into Mexico, South Africa, Australia, France, Belgium, Ireland, Switzerland, Argentina, and Brazil.

* They introduced MODESS® sanitary napkins and JOHNSON'S® Baby Oil and Baby Lotion. they also launched the first U.S. prescription birth control product, ORTHO GYNOL® Gel, in 1931.

* In 1944 they became a publicly traded company.

1946 - 1966: Continued Product Growth and Our Credo Position Johnson & Johnson as Responsible Industry Leader.

We steadily continued the growth during these decades.

* They expanded to Zimbabwe, Austria, Sweden, the Philippines, Colombia, Puerto Rico, the Netherlands, India, Scotland, Pakistan, Zambia, Venezuela, Italy, Malaysia and Portugal.

* New companies formed or acquired included:

o ETHICON, Inc., Personal Products Company (products related to women's health);

o McNeil Laboratories, Inc. (bringing us TYLENOL® acetaminophen);

o European pharmaceutical companies Cilag Chemie, A.G. and Janssen Pharmaceutica, and Codman & Shurtleff, Inc. (medical and surgical instruments).

* In 1963 Ortho Pharmaceutical began marketing its first birth control pill, ORTHO-NOVUM® 10 mg.

1966 - 1986: Medical Advances Create Groundbreaking Products their operating companies pioneered several important medical advances during this period. The acquisition of Frontier Contact Lenses would grow into their vision care business, the pioneer in disposable contact lenses. In 1985 they expanded to China. They introduced a wide range of groundbreaking products during these decades including:

* RhoGAM® a life saving treatment for hemolytic disease in newborns.

* HALDOL® (haloperidol), the gold standard for treating schizophrenia for over 25 years.

* MONISTAT® (miconazole nitrate) Cream, a milestone product for women's health.

* VICRYL™ Synthetic absorbable sutures, an important new tool for surgeons.

* The PROXIMATE® Linear Stapler, a new way to close surgical incisions without sutures.

* ORTHOCLONE® OKT3, the first therapeutic monoclonal antibody to treat the rejection of transplanted organs.

1986 - 2008: Industry Leadership Enhanced by Acquisitions and Internal Development

From the 1980s to the present, they continue to grow through acquisitions and internally developed businesses that gave them leadership positions in a number of areas.

* they acquired Life Scan, Inc. (blood glucose monitors for diabetics), Neutrogena Corporation, and skin care brands such as CLEAN